These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1239 related articles for article (PubMed ID: 7992101)

  • 1. Photodynamic therapy in dermatology with porfimer sodium and benzoporphyrin derivative: an update.
    Lui H
    Semin Oncol; 1994 Dec; 21(6 Suppl 15):11-4. PubMed ID: 7992101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photosensitizers in photodynamic therapy.
    Levy JG
    Semin Oncol; 1994 Dec; 21(6 Suppl 15):4-10. PubMed ID: 7992105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of photodynamic therapy in bone marrow purging.
    Mulroney CM; Glück S; Ho AD
    Semin Oncol; 1994 Dec; 21(6 Suppl 15):24-7. PubMed ID: 7992104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy of lung cancer.
    Lam S
    Semin Oncol; 1994 Dec; 21(6 Suppl 15):15-9. PubMed ID: 7992102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy and cancer of the esophagus.
    Marcon NE
    Semin Oncol; 1994 Dec; 21(6 Suppl 15):20-3. PubMed ID: 7992103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.
    Wang Y; Lin Y; Zhang HG; Zhu J
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):813-21. PubMed ID: 26581214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative skin phototoxicity in mice with two photosensitizing drugs: benzoporphyrin derivative monoacid ring A and porfimer sodium (Photofrin).
    Wolford ST; Novicki DL; Kelly B
    Fundam Appl Toxicol; 1995 Jan; 24(1):52-6. PubMed ID: 7713343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM; Wang KK; Zinsmeister AR
    Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [History of photodynamic therapy--past, present and future].
    Kato H
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):8-15. PubMed ID: 8546474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ATX-S10(Na) photodynamic therapy for human skin tumors and benign hyperproliferative skin.
    Takahashi H; Itoh Y; Nakajima S; Sakata I; Iizuka H
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):257-65. PubMed ID: 15379877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy for the treatment of squamous cell carcinoma using benzoporphyrin derivative.
    Marcus J; Glassberg E; Dimino-Emme L; Yamamoto R; Moy RL; Vari SG; Papaioannou T; Pergadia VR; Snyder WJ; Grundfest WS
    J Dermatol Surg Oncol; 1994 Jun; 20(6):375-82. PubMed ID: 8014262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with systemic administration of photosensitizers in dermatology.
    Calzavara-Pinton PG; Szeimies RM; Ortel B; Zane C
    J Photochem Photobiol B; 1996 Nov; 36(2):225-31. PubMed ID: 9002266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy in dermatology: recent developments.
    Lui H; Anderson RR
    Dermatol Clin; 1993 Jan; 11(1):1-13. PubMed ID: 8435904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of photodynamic therapy on adhesion molecules and metastasis.
    Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
    J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma.
    Corti L; Toniolo L; Boso C; Colaut F; Fiore D; Muzzio PC; Koukourakis MI; Mazzarotto R; Pignataro M; Loreggian L; Sotti G
    Lasers Surg Med; 2007 Jun; 39(5):394-402. PubMed ID: 17565719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy of squamous cell carcinoma. An evaluation of a new photosensitizing agent, benzoporphyrin derivative and new photoimmunoconjugate.
    Hemming AW; Davis NL; Dubois B; Quenville NF; Finley RJ
    Surg Oncol; 1993; 2(3):187-96. PubMed ID: 8252208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy using new photosensitizer shows promise for skin tumor treatment and possibility for psoriasis treatment.
    Coulter AH
    J Clin Laser Med Surg; 1993 Jun; 11(3):149-50. PubMed ID: 10146272
    [No Abstract]   [Full Text] [Related]  

  • 18. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma.
    Oseroff AR; Blumenson LR; Wilson BD; Mang TS; Bellnier DA; Parsons JC; Frawley N; Cooper M; Zeitouni N; Dougherty TJ
    Lasers Surg Med; 2006 Jun; 38(5):417-26. PubMed ID: 16788928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).
    Fingar VH; Kik PK; Haydon PS; Cerrito PB; Tseng M; Abang E; Wieman TJ
    Br J Cancer; 1999 Apr; 79(11-12):1702-8. PubMed ID: 10206280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration].
    Gonschior P; Erdemci A; Gerheuser F; Gonschior GM; Mack B; Kolbe T; Goetz AE; Höfling B
    Z Kardiol; 1991 Dec; 80(12):738-45. PubMed ID: 1837968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.